Evidence map›Paper›PMID 25320295›Full record

ArticleJournal of virology2015

Tetramer enrichment reveals the presence of phenotypically diverse hepatitis C virus-specific CD8+ T cells in chronic infection.

Katja Nitschke, Tobias Flecken, Julia Schmidt, Emma Gostick, Matthias Marget, Christoph Neumann-Haefelin, Hubert E Blum, David A Price, Robert Thimme

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. Double Positive CD4Cells · 2023
    Article
  2. Review
  3. Review
  4. Article
  5. Lymphocyte Landscape after ChronicInternational journal of molecular sciences · 2020
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Immunopathogenesis of Hepatitis C Virus Infection.Gastroenterology clinics of North America · 2015
    Review
  16. Priming persistence of HCV.Oncotarget · 2015
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Katja NitschkeDepartment of Medicine II, University Hospital Freiburg, Freiburg, Germany Faculty of Biology, University of Freiburg, Freiburg, Germany.
Tobias FleckenDepartment of Medicine II, University Hospital Freiburg, Freiburg, Germany Faculty of Biology, University of Freiburg, Freiburg, Germany Spemann Graduate School of Biology and Medicine, University of Freiburg, Freiburg, Germany.
Julia SchmidtDepartment of Medicine II, University Hospital Freiburg, Freiburg, Germany.
Emma GostickInstitute of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom.
Matthias MargetInstitute of Transfusion Medicine, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Christoph Neumann-HaefelinDepartment of Medicine II, University Hospital Freiburg, Freiburg, Germany.
Hubert E BlumDepartment of Medicine II, University Hospital Freiburg, Freiburg, Germany.
David A PriceInstitute of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom.
Robert ThimmeDepartment of Medicine II, University Hospital Freiburg, Freiburg, Germany robert.thimme@uniklinik-freiburg.de.
University Medical Center Freiburg · DECardiff University · GBUniversity Medical Center Hamburg-Eppendorf · DEUniversity of Freiburg · DE

Funding

Wellcome Trust 100326
6 · The paper itself

Abstract

unlabelledVirus-specific CD8(+) T cells are rarely detectable ex vivo by conventional methods during chronic hepatitis C virus (HCV) infection. In this study, however, we were able to detect and characterize HCV-specific CD8(+) T cells in all chronically HCV genotype 1a-infected, HLA-A*02:01-positive patients analyzed by performing major histocompatibility complex (MHC) class I tetramer enrichment. Two-thirds of these enriched HCV-specific CD8(+) T-cell populations displayed an effector memory phenotype, whereas, surprisingly, one-third displayed a naive-like phenotype despite ongoing viral replication. CD8(+) T cells with an effector memory phenotype could not expand in vitro, suggesting exhaustion of these cells. Interestingly, some of the naive-like CD8(+) T cells proliferated vigorously upon in vitro priming, whereas others did not. These differences were linked to the corresponding viral sequences in the respective patients. Indeed, naive-like CD8(+) T cells from patients with the consensus sequence in the corresponding T-cell epitope did not expand in vitro. In contrast, in patients displaying sequence variations, we were able to induce HCV-specific CD8(+) T-cell proliferation, which may indicate infection with a variant virus. Collectively, these data reveal the presence of phenotypically and functionally diverse HCV-specific CD8(+) T cells at very low frequencies that are detectable in all chronically infected patients despite viral persistence. IMPORTANCE: In this study, we analyzed CD8(+) T-cell responses specific for HLA-A*02:01-restricted epitopes in chronically HCV-infected patients, using MHC class I tetramer enrichment. Importantly, we could detect HCV-specific CD8(+) T-cell populations in all patients. To further characterize these HCV-specific CD8(+) T-cell populations that are not detectable using conventional techniques, we performed phenotypic, functional, and viral sequence analyses. These data revealed different mechanisms for CD8(+) T-cell failure in HCV infection, including T-cell exhaustion, viral escape, and functional impairment of naive-like HCV-specific CD8(+) T cells.

Indexed as

AdultAgedCD8-Positive T-LymphocytesCell ProliferationFemaleHepacivirusHepatitis C, ChronicHumansImmunologic MemoryMaleMiddle AgedPhenotypeT-Lymphocyte SubsetsYoung Adult

Identifiers

PMID25320295
PMCPMC4301109
OpenAlexW2170266465

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.